Prophylactic Bowel Regimen for Hospitalized Adults

Initial Pharmacologic Prophylaxis (NCCN)

Initiate a stimulant laxative (senna or bisacodyl 10–15 mg daily, titrated up to three times daily) at hospital admission or when risk factors such as postoperative status, opioid use, immobility, or advanced age are present, aiming for one soft, non‑forced bowel movement every 1–2 days. 1
Start the stimulant laxative immediately when constipation risk factors are identified; bisacodyl 10–15 mg daily (titrate to three doses) or senna 2–3 tablets twice‑to‑three times daily are acceptable first‑line options. 1
Do not use docusate (stool softener) for prophylaxis because evidence shows no benefit. (Evidence level: low‑quality, no demonstrated efficacy). 6
Polyethylene glycol (PEG ≈ 17 g in 8 oz water) twice daily with adequate fluid intake is an acceptable alternative first‑line stimulant. 6

Encourage increased oral fluid intake as part of routine bowel‑regimen support. 2
Increase dietary fiber only when the patient can maintain sufficient fluid intake and physical activity; otherwise fiber may be ineffective. 2
Promote ambulation or appropriate exercise when feasible to aid bowel motility. 2
Supplemental medicinal fiber (e.g., psyllium) is ineffective and may worsen constipation; it should be avoided. 6

Rule out fecal impaction (especially if diarrhea co‑exists) before adding further therapy. 1
Exclude mechanical obstruction via physical exam, abdominal radiograph, and consider gastro‑intestinal consultation when indicated. 1
Correct reversible metabolic contributors (e.g., hyper‑calcemia, hypokalemia, hypothyroidism, uncontrolled diabetes). 1
Discontinue non‑essential constipating medications (e.g., anticholinergics, certain antihypertensives). 1

Add bisacodyl rectal suppositories (once‑daily to twice‑daily) to oral stimulant when constipation persists. 1
Add PEG (1 capful in 8 oz water) twice daily as an adjunct. 1
Consider lactulose (30–60 mL 2–4 times daily) as an osmotic laxative adjunct. 1
Sorbitol (30 mL every 2 hours × 3, then PRN) may be used as an additional osmotic agent. 1
Magnesium hydroxide (30–60 mL daily to twice daily) or magnesium citrate (8 oz daily) are viable adjuncts. 1

Use glycerine suppositories ± mineral‑oil retention enema; if ineffective, proceed to manual disimpaction after analgesic ± anxiolytic pre‑medication. 1
Perform tap‑water enemas repeatedly until the effluent is clear. 1

Prophylactic bowel regimen is mandatory for virtually all patients receiving opioids because tolerance to opioid‑induced constipation does not develop. (Strong recommendation). [6][10]

Naldemedine is the first‑choice PAMORA, supported by high‑quality evidence. (Strong recommendation). 8
Naloxegol is a second‑choice PAMORA, supported by moderate‑quality evidence. (Strong recommendation). 8
Methylnaltrexone (0.15 mg/kg subcutaneously every other day, max once daily) is an alternative PAMORA with documented efficacy. (Strong recommendation). 11
PAMORAs must not be used in postoperative ileus or confirmed mechanical bowel obstruction. (Contraindication). 11

Lubiprostone – FDA‑approved for opioid‑induced constipation in non‑cancer pain; may be considered when PAMORAs are unsuitable. 11
Linaclotide – FDA‑approved for idiopathic constipation only; not first‑line for OIC but may be used off‑label. 11
Metoclopramide 10–20 mg orally four times daily as a prokinetic adjunct when gastroparesis contributes to constipation. 11

Avoid rectal suppositories or enemas in patients with neutropenia or thrombocytopenia due to bleeding risk. 6
Limit sodium‑phosphate‑containing bowel preparations to ≤ once daily in patients at risk for renal dysfunction; prefer alternative agents. 6
Use enemas sparingly because of potential electrolyte disturbances. 6

Do not rely on docusate alone; it provides no proven benefit. 6
Do not delay initiation of prophylactic laxatives until constipation manifests in at‑risk patients. (Strong recommendation). [6][10]
Do not employ PAMORAs as first‑line therapy; traditional laxatives should be exhausted first. (Strong recommendation). 8

Achieve one soft, non‑forced bowel movement every 1–2 days without straining or pain. (Target outcome). 1